Gastroenterology

Heparanase-specific shRNA: A novel therapeutic strategy in human gastric cancer

EUREKALERT Contact: Ye-Ru Wang wjg@wjgnet.com World Journal of Gastroenterology Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers....

powered by

Sucampo Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG

Sucampo Pharma Europe, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today presented additional clinical data for lubiprostone (Amitiza®) at GASTRO 2009 UEGF/WCOG, the...

powered by

Interim Data From A Clinical Trial Evaluating GI Dynamics' EndoBarrier™ Gastrointestinal Liner In...

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced that interim data from its ongoing clinical study of the EndoBarrier™ Gastrointestinal Liner in obese patients with type 2...

powered by

ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009...

ChemoCentryx, Inc., announced today that Phase II/III clinical data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with...

powered by

D. Brent Polk To Lead Pediatrics Programs

D. Brent Polk has been named chair of the Department of Pediatrics at the Keck School of Medicine of USC and chair of pediatrics and vice president of academic affairs at Childrens Hospital Los Angeles, effective April 1, 2010....

powered by

ProVation EHR and MD software to be implemented at North Shore Gastroenterology and Endoscopy...

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that North Shore Gastroenterology and Endoscopy Centers has selected its ProVation® MD software for...

powered by

Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable...

Posted on: Monday, 23 November 2009, 07:30 CST THE WOODLANDS, Texas, Nov. 23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that top-line data from its Phase 2 clinical study with LX1031...

powered by

Interim Data From A Clinical Trial Evaluating GI Dynamics' EndoBarrierT Gastrointestinal Liner In...

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that interim data from its ongoing clinical study of the EndoBarrierT Gastrointestinal Liner in obese patients with...

powered by

AmSurg Names John W. Popp, Jr., M.D. To Board of Directors

AmSurg Corp. (NASDAQ: AMSG), today announced the appointment of John W. Popp, Jr., M.D. to its Board of Directors. Dr. Popp is Clinical Professor of Medicine at the University of South Carolina School of Medicine and a Medical...

powered by

Hepatocellular Cancer Prognosis: Study findings from Yokohama City University,...

Researchers detail in 'Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas,' new data in hepatocellular cancer. "This study evaluated the efficacy of repeat hepatic resection for recurrent...

powered by
1 2 3 4 5 next »